Sterilising the mentally ill

I submitted a Freedom of Information request on how many adverse events are reported to the drug regulators (The MHRA) by Psychologists and Psychiatrists. In 2017 no psychologists working within the mental health industry reported any adverse effects from mental health treatments and only 31 adverse effects were reported by psychiatrists. The government gave me the results from my Freedom of Information Request in the yearly breakdown format like I asked for that can be viewed and downloaded for free online via the intermedery Freedom of Information request service whatdotheyknow at:  https://www.whatdotheyknow.com/user/daryl_brown I have written 2 articles on the subject and asked the President of the Royal College of Psychiatrists Wendy Burns if she is happy with those numbers, she didn't respond to me while she was responding to others, and she just hasn't responded. I published two articles on the matter over at Psychvictims.com 0 PSYCHOLOGISTS REPORTED ADVERSE

A quick google search of something old that I remembered from knowledge on psychiatric drug leaflets themselves... "Use in children and adolescents under 18 years of age Cipramil should normally not be used for children and adolescents under 18 years. Also, you should know that patients under 18 have an increased risk of side effects such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. Despite this, your doctor may prescribe citalopram for patients under 18 because he/she decides that this is in their best interests. If your doctor has prescribed Cipramil for a patient under 18 and you want to discuss this, please go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking Cipramil. Also, the long-term safety effects concerning growth, maturation and cognitive and behavioural development of Ci

The European Medicines Agency regulator have now made adding small print to the leaflets of SSRI and SNRI antidepressant medicines about the potential for permanent sexual interference after antidepressants a legal requirement from now on. You can read more about this at Rxisk or PostSSRISexualDysfunction.blogspot.com  or the media coverage at the Daily Mail or Psychology Today . Thank you for every specialist and unwitting sufferer of this that has made this happen, and especially thank you to Proffesor David Healy and the charity RXISK for making this happen. Please look carefully down the small print on these leaflets now to make sure the warning is actually being implemented in some form. Source: EMA,  https://www.ema.europa.eu/en/documents/other/new-product-information-wording-extracts-prac-recommendations-signals-adopted-13-16-may-2019-prac_en.pdf

The Rxisk Prize has now raised $60,000 out of the $100,000 target to raise awareness about Post-SSRI Sexual Dysfunction. Keep it going and it will get there! It will be a significant and important milestone if it can be reached.